LISA RAYMOND-PRINZ: Open Payments
NPI 1033766498 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 31 payments from 6 companies in 2025. Trend: 2023 $754 · 2024 $769 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $293 |
| Ardelyx, Inc. | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 4 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| GENZYME CORPORATION | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: RINVOQ, IBSRELA, LINZESS, VOQUEZNA, CREON, DUPIXENT, ENTYVIO, ZENPEP.
Industry payments across LA — which companies pay providers there.
